Letters Strategies for statins

Treat to target benefits no one

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39493.435556.1F (Published 21 February 2008) Cite this as: BMJ 2008;336:406
  1. D Graham Mackenzie, consultant in public health medicine,
  2. Philip Rutledge, consultant in medicines management
  1. 1NHS Lothian, Edinburgh EH8 9RS
  1. gm{at}nhs.net

Donner-Banzhoff and Sönnichsen highlight the lack of evidence for “treating to target” with statins.1 Treatment targets can lead to an escalation of treatment that is not evidence based, drain clinical resources through repeat clinic visits and blood tests, and can lead …

View Full Text

Log in

Log in through your institution


* For online subscription